In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

At the Mount Sinai Health System we have successfully translated many algorithms from concept to testing and clinical care, in ways that have led to financial savings and improved patient outcomes.